Their PFE stock forecasts range from $44.00 to $76.00. On average, they predict Pfizer's stock price to reach $57.26 in the next twelve months. This suggests a possible upside of 23.1% from the stock's current price.
Full Answer
Should you sell Pfizer stock now?
Pfizer Inc. ‘s prostrate cancer medicine Xtandi is in the crosshairs of a growing campaign for the government to seize patent rights to bolster competition. Sen. Elizabeth Warren (D-Mass.) and two other lawmakers are pushing the Biden administration to ...
Why is Pfizer stock declining?
Disclaimer | Accessibility Statement | Commerce Policy | Made In NYC | Stock quotes by finanzen.net Shares of Pfizer (NYSE ... Today's decline appears to be a by-product of the overall market ...
Should I Buy More Pfizer?
Pfizer Inc. (NYSE:PFE) trade information Upright in the red during last session for losing -0.39%, in the last five days PFE remained trading in the red while hitting it’s week-highest on Friday, 06/11/21 when the stock touched $39.15 price level, adding ...
Is Pfizer a good stock?
So, is PFE stock a good investment right now? PFE stock isn’t a buy right now, according to technical analysis. The company, on the other hand, is likely to record positive growth in the fourth ...
Should I buy or sell Pfizer stock right now?
19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last twelve months. There are currently 10 hold ratings and...
What is Pfizer's stock price forecast for 2022?
19 brokers have issued 12-month price targets for Pfizer's shares. Their forecasts range from $44.00 to $76.00. On average, they anticipate Pfizer'...
How has Pfizer's stock performed in 2022?
Pfizer's stock was trading at $59.05 on January 1st, 2022. Since then, PFE shares have decreased by 15.4% and is now trading at $49.97. View the b...
Are investors shorting Pfizer?
Pfizer saw a increase in short interest during the month of May. As of May 31st, there was short interest totaling 77,200,000 shares, an increase o...
When is Pfizer's next earnings date?
Pfizer is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022. View our earnings forecast for Pfizer .
How were Pfizer's earnings last quarter?
Pfizer Inc. (NYSE:PFE) announced its quarterly earnings results on Tuesday, May, 3rd. The biopharmaceutical company reported $1.62 EPS for the quar...
How often does Pfizer pay dividends? What is the dividend yield for Pfizer?
Pfizer declared a quarterly dividend on Thursday, April 28th. Investors of record on Friday, May 13th will be paid a dividend of $0.40 per share on...
Is Pfizer a good dividend stock?
Pfizer(NYSE:PFE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 3.09%. Pfizer has been increasing its dividend fo...
What guidance has Pfizer issued on next quarter's earnings?
Pfizer issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $6.25-$6.45 for the period, comp...
Who is the CEO of Pfizer?
Pfizer Inc. ( NYSE:PFE) CEO Albert Bourla got investors both excited and scared during the company’s most recent quarterly earnings call. The company rang up $3.5 billion in sales off its coronavirus vaccine, BNT162b2, which it developed in partnership with BioNTech SE ( NASDAQ:BNTX). Of course, that could be just the tip ...
Does Pfizer have an EUA?
Of course, Pfizer has stiff competition – there are multiple companies with Emergency Use Authorization (EUA) from the FDA and regulators in other countries. That could cap its potential growth, but the company still forecasts growth from the vaccine.
Does Pfizer pay dividends?
Pfizer pays a consistent quarterly dividend that has been dependable for over a decade. It regularly pays out and even increases the dividend by $0.01 to $0.02 every year. It just so happens that the company also paid a special dividend of $1.967 in November 2020, which coincides with Berkshire’s Pfizer investment.
Latest Stocks Videos
In The Money: Groundhog Day: Mega-Cap Tech Stocks Out From the Shadows? Feb 02, 2022
Trefis
Trefis is an interactive financial community structured around trends, forecasts and insights related to some of the most popular stocks in the US. Whereas most finance sites simply give you the facts about where a stock has been and what a company has done in the past, Trefis focuses entirely on the future.
How many shots will Pfizer sell in 2021?
In its first-quarter earnings news release, BioNTech said it had secured contracts for 1.8 billion doses in 2021.
How much does Xeljanz make?
Xeljanz, which is facing scrutiny for a recent post-marketing study, generated $2.44 billion, rising 9%. Vyndaqel and Vyndamax, which treat a condition that can cause heart failure, brought in $1.29 billion. For 2021, analysts surveyed by FactSet call for Pfizer to earn $3.71 a share, minus some items, up 67%.
Is Pfizer going to do a delta?
Pfizer stock rose into breakout territory in late July after the company said it's planning to tackle the delta variant with a specific Covid vaccine. The company also is testing out a third dose of its BioNTech ( BNTX )-partnered Covid vaccine as a booster shot. But U.S. officials still aren't sold on whether boosters will be needed.
Does Pfizer stay at 12x earnings?
Generally, high-quality businesses like Pfizer don’t stay at 12-13x earnings forever, after all. On the date of publication, Ian Bezek did not have (either directly or indirectly) any positions in the securities mentioned in this article.
Is Pfizer a winner?
Just from the headlines, you’d think Pfizer stock was a major winner. After all, the company has played a pivotal role in getting one of the first approved novel coronavirus vaccines working and ready for the general public at record speed. But that scientific success hasn’t translated to its share price.
Does Pfizer lose drugs?
Furthermore, Pfizer can shrug off the loss of drugs due to patent expiry or something in the pipeline not working. While Pfizer’s huge size limits its upside from any one particular success, such as this Covid-19 achievement, it also keeps investors safe from periods of bad luck as well.
Is Pfizer stock reliant on any one drug?
However, as one of the world’s largest pharma companies, Pfizer stock is not reliant on any one drug or product line to make up the lion’s share of its earnings.
Did PFE stock jump?
Yes, PFE stock did jump a bit in November, reach ing its highest level since 2018. However, shares have fallen back once again. That underperformance is particularly disappointing given the massive run that the stock market as a whole has enjoyed.
Is PFE stock a winner in 2020?
While that might explain why PFE stock hasn’t been a huge winner in 2020 despite the vaccine success, it does speak to Pfizer’s strength more broadly. There are few companies that could launch a new product like the Covid-19 vaccine and not have it make a huge impact on earnings.
How much will Pfizer's revenue grow in 2026?
Before accounting for contributions from coronavirus vaccine sales, Pfizer expects top-line revenue to grow by at least 6% annually between now and 2026. The company expects an even better performance along the bottom line with earnings that could rise by a double-digit percentage.
How much money does Pfizer receive from Viatris?
Pfizer will receive about $12 billion from Viatris this year in addition to operating cash flow that reached between $10 and $11 billion last year. That gives Pfizer plenty of cash to fuel a torrent of co-development deals over the next few years while increasing its dividend payout at the same time.
Is Pfizer stock good?
Pfizer will probably make good on its double-digit bottom-line growth estimate, but the stock price has been a bit depressed because investors are worried that incoming patent expirations for today's blockbuster drugs will prevent Pfizer from growing at more than a snail's pace after 2026.
How much does Pfizer cost?
Pfizer, along with its partner BioNTech ( NASDAQ:BNTX), has received orders for over 1 billion doses of its vaccine. With a price tag of $14.70 to $19.50 per dose, this would bring Pfizer a potential $7.5 billion to $10 billion in upcoming revenue (after adjusting for a 50/50 gross profit split with BioNTech).
How much money will Pfizer make in 2020?
Without the rewards of the coronavirus vaccine, management estimates that Pfizer would realize $40.8 billion to $42.4 billion in sales for 2020 and grow that metric by 6% per year until 2025. After accounting for its vaccine (Comirnaty), however, everything changes.
How many doses of Pfizer are produced?
Management has also upped their expectations for production, estimating that Pfizer will be able to manufacture 2 billion doses of its coronavirus vaccine this year, up from a previous estimate of 1.3 billion.
Why is the FDA approving generic drugs?
Right now, the U.S. Food and Drug Administration (FDA) is approving a record number of generic medications in order to drive down drug prices. The initiative provides much-needed relief for patients and insurers alike, but has been nothing short of nightmarish for generic drug manufacturers, such as Pfizer's former subsidiary, Upjohn.